{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:22:02Z","timestamp":1788852122860,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1208\/s12249-021-02207-3","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T20:55:33Z","timestamp":1642107333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Design of a Long-Acting Rivastigmine Transdermal Delivery System: Based on Computational Simulation"],"prefix":"10.1208","volume":"23","author":[{"given":"Xue","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"issue":"5","key":"2207_CR1","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/med.21434","volume":"37","author":"SO Bachurin","year":"2017","unstructured":"Bachurin SO, Bovina EV, Ustyugov AA. Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends. MED RES REV. 2017;37(5):1186\u2013225.","journal-title":"MED RES REV"},{"key":"2207_CR2","first-page":"S23","volume-title":"Caregiver preference for rivastigmine patches versus capsules for the treatment of alzheimer disease","author":"R BLESA","year":"2007","unstructured":"BLESA R, BALLARD C, ORGOGOZO J, LANE R, THOMAS SK. Caregiver preference for rivastigmine patches versus capsules for the treatment of alzheimer disease, vol. 69. Hagerstown, MD: Lippincott Williams & Wilkins; 2007. p. S23\u20138."},{"issue":"10","key":"2207_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40266-016-0405-y","volume":"33","author":"G Lef\u00e8vre","year":"2016","unstructured":"Lef\u00e8vre G, Callegari F, Gsteiger S, Xiong Y. Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer\u2019s Disease. DRUG AGING. 2016;33(10):725\u201336.","journal-title":"DRUG AGING"},{"issue":"5","key":"2207_CR4","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.xphs.2020.12.024","volume":"110","author":"D Zhang","year":"2021","unstructured":"Zhang D, Wang W, Hou T, Pang Y, Wang C, Wu S, Wang Q. New Delivery Route of Gambogic Acid Via Skin for Topical Targeted Therapy of Cutaneous Melanoma and Reduction of Systemic Toxicity. J PHARM SCI-US. 2021;110(5):2167\u201376.","journal-title":"J PHARM SCI-US"},{"issue":"3","key":"2207_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1773-2247(14)50041-X","volume":"24","author":"KB Ita","year":"2014","unstructured":"Ita KB. Transdermal drug delivery: progress and challenges. J DRUG DELIV SCI TEC. 2014;24(3):245\u201350.","journal-title":"J DRUG DELIV SCI TEC"},{"issue":"9","key":"2207_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1461-5347(00)00295-9","volume":"3","author":"A Naik","year":"2000","unstructured":"Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Technol Today. 2000;3(9):318\u201326.","journal-title":"Pharm Sci Technol Today"},{"issue":"10","key":"2207_CR7","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1517\/17425255.2015.1063615","volume":"11","author":"D Selzer","year":"2015","unstructured":"Selzer D, Neumann D, Schaefer UF. Mathematical models for dermal drug absorption. EXPERT OPIN DRUG MET. 2015;11(10):1567\u201383.","journal-title":"EXPERT OPIN DRUG MET"},{"key":"2207_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119737","volume":"588","author":"T Shi","year":"2020","unstructured":"Shi T, Lv Y, Huang W, Fang Z, Qi J, Chen Z, Zhao W, Wu W, Lu Y. Enhanced transdermal delivery of curcumin nanosuspensions: A mechanistic study based on co-localization of particle and drug signals. INT J PHARMACEUT. 2020;588:119737.","journal-title":"INT J PHARMACEUT"},{"issue":"4","key":"2207_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/pharmaceutics11040173","volume":"11","author":"A Puri","year":"2019","unstructured":"Puri A, Bhattaccharjee S, Zhang W, Clark M, Singh O, Doncel G, Banga A. Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV. PHARMACEUTICS. 2019;11(4):173.","journal-title":"PHARMACEUTICS"},{"issue":"2","key":"2207_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40204-019-0114-9","volume":"8","author":"I Jafri","year":"2019","unstructured":"Jafri I, Shoaib MH, Yousuf RI, Ali FR. Effect of permeation enhancers on in vitro release and transdermal delivery of lamotrigine from Eudragit\u00aeRS100 polymer matrix-type drug in adhesive patches. Progress in Biomaterials. 2019;8(2):91\u2013100.","journal-title":"Progress in Biomaterials"},{"key":"2207_CR11","first-page":"349","volume":"12","author":"R Akram","year":"2018","unstructured":"Akram R, Ahmad M, Abrar A, Sarfraz RM, Mahmood A. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride. 2018;12:349\u201364.","journal-title":"Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride."},{"key":"2207_CR12","doi-asserted-by":"crossref","unstructured":"Defraeye T, Bahrami F, Ding L, Malini RI, Terrier A, Rossi RM. Predicting Transdermal Fentanyl Delivery Using Mechanistic Simulations for Tailored Therapy. FRONT PHARMACOL. 2020;11.","DOI":"10.3389\/fphar.2020.585393"},{"key":"2207_CR13","doi-asserted-by":"crossref","unstructured":"Nair AB, Gupta S, Al-Dhubiab BE, Jacob S, Shinu P, Shah J, Morsy MA, SreeHarsha N, Attimarad M, Venugopala KN, Akrawi SH. Effective Therapeutic Delivery and Bioavailability Enhancement of Pioglitazone Using Drug in Adhesive Transdermal Patch. PHARMACEUTICS. 2019;11(7).","DOI":"10.3390\/pharmaceutics11070359"},{"key":"2207_CR14","doi-asserted-by":"crossref","unstructured":"La Count TD, Zhang Q, Murawsky M, Hao J, Ghosh P, Dave K, Raney SG, Talattof A, Kasting GB, Li SK. Evaluation of Heat Effects on Transdermal Nicotine Delivery In Vitro and In Silico Using Heat-Enhanced Transport Model Analysis. The AAPS Journal. 2020;22(4).","DOI":"10.1208\/s12248-020-00457-w"},{"issue":"3","key":"2207_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1021\/acs.molpharmaceut.0c01054","volume":"18","author":"D Yang","year":"2021","unstructured":"Yang D, Liu C, Piao H, Quan P, Fang L. Enhanced Drug Loading in the Drug-in-Adhesive Transdermal Patch Utilizing a Drug\u2013Ionic Liquid Strategy: Insight into the Role of Ionic Hydrogen Bonding. MOL PHARMACEUT. 2021;18(3):1157\u201366.","journal-title":"MOL PHARMACEUT"},{"key":"2207_CR16","doi-asserted-by":"crossref","unstructured":"Zeng L, Song W, He W, Zhang J, Wang Y, Bian J, Mao Z, Quan D, Liu J. Unconventional Passive Enhancement of Transdermal Drug Delivery: toward a Mechanistic Understanding of Penetration Enhancers Releasing from Acrylic Pressure-Sensitive Adhesive of Patches. PHARM RES-DORDR. 2020;37(9).","DOI":"10.1007\/s11095-020-02901-0"},{"issue":"9","key":"2207_CR17","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1016\/j.xphs.2017.03.003","volume":"106","author":"S Yamamoto","year":"2017","unstructured":"Yamamoto S, Karashima M, Arai Y, Tohyama K, Amano N. Prediction of Human Pharmacokinetic Profile After Transdermal Drug Application Using Excised Human Skin. J PHARM SCI-US. 2017;106(9):2787\u201394.","journal-title":"J PHARM SCI-US"},{"key":"2207_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ejpb.2018.02.032","volume":"127","author":"K Rizi","year":"2018","unstructured":"Rizi K, Mohammed IK, Xu K, Kinloch AJ, Charalambides MN, Murdan S. A systematic approach to the formulation of anti-onychomycotic nail patches. EUR J PHARM BIOPHARM. 2018;127:355\u201365.","journal-title":"EUR J PHARM BIOPHARM"},{"key":"2207_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120560","volume":"602","author":"D Yang","year":"2021","unstructured":"Yang D, Liu C, Ding D, Quan P, Fang L. The molecular design of drug-ionic liquids for transdermal drug delivery: Mechanistic study of counterions structure on complex formation and skin permeation. INT J PHARMACEUT. 2021;602:120560.","journal-title":"INT J PHARMACEUT"},{"key":"2207_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2019.104794","volume":"224","author":"MK Chauhan","year":"2019","unstructured":"Chauhan MK, Sharma PK. Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia. CHEM PHYS LIPIDS. 2019;224:104794.","journal-title":"CHEM PHYS LIPIDS"},{"key":"2207_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120503","volume":"601","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu C, Xu W, Quan P, Luo Z, Yang D, Fang L. An investigation on percutaneous permeation of flurbiprofen enantiomers: The role of molecular interaction between drug and skin components. INT J PHARMACEUT. 2021;601:120503.","journal-title":"INT J PHARMACEUT"},{"issue":"5","key":"2207_CR22","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.apsb.2019.11.014","volume":"10","author":"Z Luo","year":"2020","unstructured":"Luo Z, Liu C, Quan P, Yang D, Zhao H, Wan X, Fang L. Mechanistic insights of the controlled release capacity of polar functional group in transdermal drug delivery system: the relationship of hydrogen bonding strength and controlled release capacity. ACTA PHARM SIN B. 2020;10(5):928\u201345.","journal-title":"ACTA PHARM SIN B"},{"issue":"10","key":"2207_CR23","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1080\/03639045.2018.1483391","volume":"44","author":"M Shen","year":"2018","unstructured":"Shen M, Liu C, Wan X, Farah N, Fang L. Development of a daphnetin transdermal patch using chemical enhancer strategy: insights of the enhancement effect of Transcutol P and the assessment of pharmacodynamics. DRUG DEV IND PHARM. 2018;44(10):1642\u20139.","journal-title":"DRUG DEV IND PHARM"},{"issue":"5","key":"2207_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1208\/s12249-021-02055-1","volume":"22","author":"Z Luo","year":"2021","unstructured":"Luo Z, Liu C, Quan P, Zhang Y, Fang L. Effect of Chemical Penetration Enhancer-Adhesive Interaction on Drug Release from Transdermal Patch: Mechanism Study Based on FT-IR Spectroscopy, 13C NMR Spectroscopy, and Molecular Simulation. AAPS PHARMSCITECH. 2021;22(5):198.","journal-title":"AAPS PHARMSCITECH"},{"key":"2207_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jconrel.2015.05.263","volume":"210","author":"Y Yang","year":"2015","unstructured":"Yang Y, Manda P, Pavurala N, Khan MA, Krishnaiah YS. Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems. J CONTROL RELEASE. 2015;210:58\u201366.","journal-title":"J CONTROL RELEASE"},{"issue":"06","key":"2207_CR26","first-page":"735","volume":"51","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang Q. Effect of Determination Method on in vitro Release Profiles of Rivastigmine Transdermal Patches and Correlation between Penetration in vitro and Absorption in vivo. Chinese Journal of Pharmaceuticals. 2020;51(06):735\u201340.","journal-title":"Chinese Journal of Pharmaceuticals"},{"issue":"2","key":"2207_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0169-409X(01)00113-2","volume":"48","author":"YN Kalia","year":"2001","unstructured":"Kalia YN, Guy RH. Modeling transdermal drug release. ADV DRUG DELIVER REV. 2001;48(2):159\u201372.","journal-title":"ADV DRUG DELIVER REV"},{"issue":"1","key":"2207_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/sj.clpt.6100242","volume":"83","author":"G Lef\u00e8vre","year":"2007","unstructured":"Lef\u00e8vre G, S\u0119dek G, Jhee SS, Leibowitz MT, Huang H, Enz A, Maton S, Ereshefsky L, Pommier F, Schmidli H, Appel-Dingemanse S. Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients. CLIN PHARMACOL THER. 2007;83(1):106\u201314.","journal-title":"CLIN PHARMACOL THER"},{"issue":"2","key":"2207_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0939-6411(02)00051-6","volume":"54","author":"SC Shin","year":"2002","unstructured":"Shin SC, Lee HJ. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems. EUR J PHARM BIOPHARM. 2002;54(2):201\u20136.","journal-title":"EUR J PHARM BIOPHARM"},{"issue":"8","key":"2207_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3109\/10717544.2014.889778","volume":"22","author":"S Meyer","year":"2014","unstructured":"Meyer S, Heinsohn G, Wolber R, P\u00f6rtner R, Nierle J. Confocal Raman investigation of diffusion processes in monolithic type transdermal drug delivery systems. DRUG DELIV. 2014;22(8):1103\u201310.","journal-title":"DRUG DELIV"},{"key":"2207_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120560","volume":"602","author":"D Yang","year":"2021","unstructured":"Yang D, Liu C, Ding D, Quan P, Fang L. The molecular design of drug-ionic liquids for transdermal drug delivery: Mechanistic study of counterions structure on complex formation and skin permeation. INT J PHARMACEUT. 2021;602:120560.","journal-title":"INT J PHARMACEUT"},{"key":"2207_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jconrel.2016.02.027","volume":"227","author":"W Song","year":"2016","unstructured":"Song W, Quan P, Li S, Liu C, Lv S, Zhao Y, Fang L. Probing the role of chemical enhancers in facilitating drug release from patches: Mechanistic insights based on FT-IR spectroscopy, molecular modeling and thermal analysis. J CONTROL RELEASE. 2016;227:13\u201322.","journal-title":"J CONTROL RELEASE"},{"key":"2207_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105783","volume":"161","author":"S Zhang","year":"2021","unstructured":"Zhang S, Liu C, Yang D, Ruan J, Luo Z, Quan P, Fang L. Mechanism insight on drug skin delivery from polyurethane hydrogels: Roles of molecular mobility and intermolecular interaction. EUR J PHARM SCI. 2021;161:105783.","journal-title":"EUR J PHARM SCI"},{"key":"2207_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.105009","volume":"138","author":"C Liu","year":"2019","unstructured":"Liu C, Farah N, Weng W, Jiao B, Shen M, Fang L. Investigation of the permeation enhancer strategy on benzoylaconitine transdermal patch: the relationship between transdermal enhancement strength and physicochemical properties of permeation enhancer. EUR J PHARM SCI. 2019;138:105009.","journal-title":"EUR J PHARM SCI"},{"issue":"1","key":"2207_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1208\/s12249-012-9900-6","volume":"14","author":"DP Otto","year":"2013","unstructured":"Otto DP, de Villiers MM. The Experimental Evaluation and Molecular Dynamics Simulation of a Heat-Enhanced Transdermal Delivery System. AAPS PHARMSCITECH. 2013;14(1):111\u201320.","journal-title":"AAPS PHARMSCITECH"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-02207-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-021-02207-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-02207-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T16:37:04Z","timestamp":1647275824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-021-02207-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2207"],"URL":"https:\/\/doi.org\/10.1208\/s12249-021-02207-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"54"}}